Effects of proinsulin C-peptide on nitric oxide, microvascular blood flow and erythrocyte Na+,K+-ATPase activity in diabetes mellitus type I.
about
Intracellular signalling by C-peptideProinsulin C-peptide reduces diabetes-induced glomerular hyperfiltration via efferent arteriole dilation and inhibition of tubular sodium reabsorptionDiabetic complications within the context of aging: Nicotinamide adenine dinucleotide redox, insulin C-peptide, sirtuin 1-liver kinase B1-adenosine monophosphate-activated protein kinase positive feedback and forkhead box O3Physiological effects and therapeutic potential of proinsulin C-peptideAn In Vitro Diagnostic for Multiple Sclerosis Based on C-peptide Binding to ErythrocytesC-peptide and diabetic kidney disease.Role of diabetic microvascular disease in the development of foot wounds.The effects of C-peptide on type 1 diabetic polyneuropathies and encephalopathy in the BB/Wor-rat.C-Peptide effects on renal physiology and diabetes.Role of C-Peptide in the regulation of microvascular blood flow.Synergistic effects of C-peptide and insulin on low O2-induced ATP release from human erythrocytes.Pathological consequences of C-peptide deficiency in insulin-dependent diabetes mellitus.Na,K-ATPase regulation in skeletal muscle.The clinical potential of low-level C-peptide secretion.C-Peptide and its intracellular signaling.Molecular effects of C-Peptide in microvascular blood flow regulation.Will C-peptide substitution make a difference in combating complications in insulin-deficient diabetes?Exogenous thyroxine improves glucose intolerance in insulin-resistant rats.Effect of yeast biomass with high content of carotenoids on erythrocyte deformability, NO production and Na,K-ATPase activity in healthy and LPS treated rats.Mechanisms of C-peptide-mediated rescue of low O2-induced ATP release from erythrocytes of humans with type 2 diabetes.Low O2-induced ATP release from erythrocytes of humans with type 2 diabetes is restored by physiological ratios of C-peptide and insulin.C-peptide stimulates Na+,K+-ATPase activity via PKC alpha in rat medullary thick ascending limb.
P2860
Q21342827-EB0504E7-4DFC-41B3-8FC5-25BCC5966A52Q24652602-7BB1155D-6145-46C0-90D0-D87482072921Q26749486-3DFC23C5-AC24-484D-B3E2-322F15DCF56BQ27012286-A4E01FD0-3B74-440F-A8D3-71AB30D417AFQ29400681-AA5144D6-82E2-4A62-974E-CAB40165A373Q34540591-70D5CB32-AF87-4C2D-AC02-29D0102494D1Q36920446-9464D8A3-3798-4B93-A2C3-6F2F80F5164EQ37147785-FE13B3D1-A135-4724-A95E-26816DB73F9CQ37176072-8D466186-219C-4A3D-995E-E3F40B609881Q37231760-862372AB-ACCD-4971-A39A-850E1F66076FQ37440642-F97A45CF-AEB7-4112-BACA-42CBEB656B5DQ38356851-5D5FC48F-245A-4492-8C9F-B765D32B5517Q38831589-27364A3E-8EC9-4AAC-B4A7-AE478DAC5904Q38889362-5DAC2A69-DFBE-4731-AEF5-4E1D0C984BB6Q39224484-C87823DC-43C9-4C09-88EF-AA6047B4A466Q39224550-D7A1634A-B7BD-41F5-8305-24901156B2D2Q42976555-940E186F-B59D-41D3-BBD3-6FCA76F27095Q45985513-47A5474C-8D5C-42D2-9C34-76ECDA1DE7F7Q46575822-99A31DD6-AC74-4158-8728-A37848F1A8B8Q48238409-10A31BD4-185F-43D7-94D0-643686F36099Q50463857-4925E564-EEBD-482E-A38A-95434AD5BC4EQ51537832-9C2A9860-8F1F-4F11-B23C-910A08B6AEEB
P2860
Effects of proinsulin C-peptide on nitric oxide, microvascular blood flow and erythrocyte Na+,K+-ATPase activity in diabetes mellitus type I.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Effects of proinsulin C-peptid ...... y in diabetes mellitus type I.
@ast
Effects of proinsulin C-peptid ...... y in diabetes mellitus type I.
@en
type
label
Effects of proinsulin C-peptid ...... y in diabetes mellitus type I.
@ast
Effects of proinsulin C-peptid ...... y in diabetes mellitus type I.
@en
prefLabel
Effects of proinsulin C-peptid ...... y in diabetes mellitus type I.
@ast
Effects of proinsulin C-peptid ...... y in diabetes mellitus type I.
@en
P2093
P356
P1433
P1476
Effects of proinsulin C-peptid ...... y in diabetes mellitus type I.
@en
P2093
De La Tour DD
Engelbach M
Johansson BL
Pfützner A
Pohlmann T
P304
P356
10.1042/CS0980283
P407
P50
P577
2000-03-01T00:00:00Z